Fu Yibao, Jia Jinmeng, Yue Lishu, Yang Ruiying, Guo Yongli, Ni Xin, Shi Tieliu
Center for Bioinformatics and Computational Biology, and the Institute of Biomedical Sciences, School of Life Sciences, East China Normal University, Shanghai, China.
Big Data and Engineering Research Center, Beijing Key Laboratory for Pediatric Diseases of Otolaryngology, Head and Neck Surgery, MOE Key Laboratory of Major Diseases in Children, Beijing Children's Hospital, National Center for Children's Health, Beijing Pediatric Research Institute, Capital Medical University, Beijing, China.
Front Pharmacol. 2019 Sep 13;10:1018. doi: 10.3389/fphar.2019.01018. eCollection 2019.
The rare autosomal dominant disorder acute intermittent porphyria (AIP) is caused by the deficient activity of hydroxymethylbilane synthase (HMBS). The symptoms of AIP are acute neurovisceral attacks which are induced by the dysfunction of heme biosynthesis. To better interpret the underlying mechanism of clinical phenotypes, we collected 117 gene mutations from reported individuals with AIP and evaluated the mutations' impacts on the corresponding protein structure and function. We found that several mutations with most severe clinical symptoms are located at dipyromethane cofactor (DPM) binding domain of HMBS. Mutations on these residues likely significantly influence the catalytic reaction. To infer new pathogenic mutations, we evaluated the pathogenicity for all the possible missense mutations of gene with different bioinformatic prediction algorithms, and identified 34 mutations with serious pathogenicity and low allele frequency. In addition, we found that gene may also play an important role in the mechanisms of AIP attacks. Our analysis about the distribution frequencies of the 23 variations revealed different distribution patterns among eight ethnic populations, which could help to explain the genetic basis that may contribute to population disparities in AIP prevalence. Our systematic analysis provides a better understanding for this disease and helps for the diagnosis and treatment of AIP.
罕见的常染色体显性疾病急性间歇性卟啉病(AIP)是由羟甲基bilane合酶(HMBS)活性不足引起的。AIP的症状是急性神经内脏发作,由血红素生物合成功能障碍诱发。为了更好地解释临床表型的潜在机制,我们从已报道的AIP个体中收集了117个基因突变,并评估了这些突变对相应蛋白质结构和功能的影响。我们发现,一些具有最严重临床症状的突变位于HMBS的二吡咯甲烷辅因子(DPM)结合域。这些残基上的突变可能会显著影响催化反应。为了推断新的致病突变,我们使用不同的生物信息学预测算法评估了该基因所有可能的错义突变的致病性,并鉴定出34个具有严重致病性和低等位基因频率的突变。此外,我们发现该基因在AIP发作机制中可能也起着重要作用。我们对23种变异分布频率的分析揭示了八个种族群体之间不同的分布模式,这有助于解释可能导致AIP患病率存在人群差异的遗传基础。我们的系统分析为这种疾病提供了更好的理解,并有助于AIP的诊断和治疗。